tradingkey.logo

Haleon PLC

HLN

8.820USD

+0.110+1.26%
Cierre 09/26, 16:00ETCotizaciones retrasadas 15 min
79.24BCap. mercado
54.95P/E TTM
Más Datos de Haleon PLC Compañía
Haleon plc is a consumer healthcare company. The Company's product portfolio includes five categories, including oral health, vitamins, minerals, and supplements (VMS), pain relief, respiratory health, digestive health and others. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA and LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company's digestive health and other product offerings also include skin health and smoker’s health. Its oral health brands include Sensodyne, Polident, Parodontax, and Biotene. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, and Flonase. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Fenistil.
Información de la empresa
Símbolo de cotizaciónHLN
Nombre de la empresaHaleon PLC
Fecha de salida a bolsaJul 18, 2022
Director ejecutivoMr. Brian Mcnamara
Número de empleados- -
Tipo de seguridadOrdinary Share
Fin del año fiscalJul 18
DirecciónBuilding 5, First Floor
CiudadWEYBRIDGE
Bolsa de valoresLondon Stock Exchange
PaísUnited Kingdom
Código postalKT13 0NY
Teléfono441932822000
Sitio Webhttps://www.haleon.com/
Símbolo de cotizaciónHLN
Fecha de salida a bolsaJul 18, 2022
Director ejecutivoMr. Brian Mcnamara
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Brian Mcnamara
Mr. Brian Mcnamara
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
444.67K
+0.83%
Ms. Lisa Paley
Ms. Lisa Paley
President, North America
President, North America
174.31K
+774.13%
Mr. Matt Shattock
Mr. Matt Shattock
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Jo Russell
Mr. Jo Russell
Head of Investor Relations
Head of Investor Relations
--
--
Mr. Adrian Morris
Mr. Adrian Morris
General Counsel
General Counsel
--
--
Ms. Blathnaid Bergin
Ms. Blathnaid Bergin
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Ed Petter
Mr. Ed Petter
Chief Corporate Affairs Officer
Chief Corporate Affairs Officer
--
--
Ms. Tracy Clarke
Ms. Tracy Clarke
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Sir Dave Lewis
Sir Dave Lewis
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
--
--
Mr. Keith Choy
Mr. Keith Choy
President, Asia Pacific
President, Asia Pacific
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Brian Mcnamara
Mr. Brian Mcnamara
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
444.67K
+0.83%
Ms. Lisa Paley
Ms. Lisa Paley
President, North America
President, North America
174.31K
+774.13%
Mr. Matt Shattock
Mr. Matt Shattock
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Jo Russell
Mr. Jo Russell
Head of Investor Relations
Head of Investor Relations
--
--
Mr. Adrian Morris
Mr. Adrian Morris
General Counsel
General Counsel
--
--
Ms. Blathnaid Bergin
Ms. Blathnaid Bergin
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Desglose de ingresos
Divisa: GBPActualizado: dom., 6 de jul
Divisa: GBPActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Por negocioGBP
Nombre
Ganancia
Proporción
Oral health
880.00M
30.84%
Pain relief
661.00M
23.17%
Respiratory health
465.00M
16.30%
Digestive health and other
431.00M
15.11%
Vitamins, minerals and supplements
416.00M
14.58%
Por regiónGBP
Nombre
Ganancia
Proporción
EMEA and LatAm
1.19B
41.64%
Northern America
980.00M
34.35%
APAC
685.00M
24.01%
Por negocio
Por región
Por negocioGBP
Nombre
Ganancia
Proporción
Oral health
880.00M
30.84%
Pain relief
661.00M
23.17%
Respiratory health
465.00M
16.30%
Digestive health and other
431.00M
15.11%
Vitamins, minerals and supplements
416.00M
14.58%
Estadísticas de accionistas
Actualizado: sáb., 16 de ago
Actualizado: sáb., 16 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Dodge & Cox
3.49%
Fidelity Management & Research Company LLC
2.19%
ClearBridge Investments, LLC
0.71%
Harding Loevner LP
0.51%
Fidelity Institutional Asset Management
0.32%
Otro
92.79%
Accionistas
Accionistas
Proporción
Dodge & Cox
3.49%
Fidelity Management & Research Company LLC
2.19%
ClearBridge Investments, LLC
0.71%
Harding Loevner LP
0.51%
Fidelity Institutional Asset Management
0.32%
Otro
92.79%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor/Hedge Fund
5.75%
Investment Advisor
5.42%
Hedge Fund
0.78%
Research Firm
0.65%
Bank and Trust
0.17%
Family Office
0.07%
Family Office
0.06%
Family Office
0.06%
Individual Investor
0.02%
Otro
87.02%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
1049
577.49M
12.86%
-190.91M
2025Q1
1077
574.94M
12.79%
-194.57M
2024Q4
1094
745.67M
16.47%
-9.34M
2024Q3
1096
717.29M
15.74%
-81.04M
2024Q2
1078
719.27M
15.75%
-155.43M
2024Q1
1041
707.36M
15.49%
-53.58M
2023Q4
993
691.96M
14.98%
-58.05M
2023Q3
933
688.70M
14.92%
-37.88M
2023Q2
891
677.74M
14.68%
-44.11M
2023Q1
842
667.68M
14.46%
-14.30M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Dodge & Cox
169.15M
3.77%
-9.59M
-5.37%
Mar 31, 2025
Fidelity Management & Research Company LLC
97.16M
2.16%
+2.47M
+2.61%
Mar 31, 2025
ClearBridge Investments, LLC
32.59M
0.73%
-208.31K
-0.64%
Mar 31, 2025
Harding Loevner LP
23.07M
0.51%
-1.05M
-4.37%
Mar 31, 2025
Fidelity Institutional Asset Management
14.29M
0.32%
+153.75K
+1.09%
Mar 31, 2025
Wellington Management Company, LLP
18.70M
0.42%
+3.37M
+22.00%
Mar 31, 2025
Managed Account Advisors LLC
4.84M
0.11%
+129.49K
+2.75%
Mar 31, 2025
Sculptor Capital Management, Inc
10.85M
0.24%
+1.96M
+22.09%
Mar 31, 2025
Aristotle Capital Management, LLC
8.44M
0.19%
-314.11K
-3.59%
Mar 31, 2025
Parametric Portfolio Associates LLC
7.67M
0.17%
+569.43K
+8.02%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de sep
Actualizado: sáb., 6 de sep
Nombre
Proporción
VanEck Pharmaceutical ETF
4.79%
GMO International Quality ETF
4.23%
Franklin ClearBridge Enhanced Income ETF
1.88%
Rockefeller Global Equity ETF
1.17%
One Global ETF
0.78%
ActivePassive International Equity ETF
0.36%
SP Funds S&P World (ex-US) ETF
0.28%
Avantis International Equity ETF
0.1%
Avantis Responsible International Equity ETF
0.09%
Avantis International Large Cap Value ETF
0%
Ver más
VanEck Pharmaceutical ETF
Proporción4.79%
GMO International Quality ETF
Proporción4.23%
Franklin ClearBridge Enhanced Income ETF
Proporción1.88%
Rockefeller Global Equity ETF
Proporción1.17%
One Global ETF
Proporción0.78%
ActivePassive International Equity ETF
Proporción0.36%
SP Funds S&P World (ex-US) ETF
Proporción0.28%
Avantis International Equity ETF
Proporción0.1%
Avantis Responsible International Equity ETF
Proporción0.09%
Avantis International Large Cap Value ETF
Proporción0%
Dividendos
Un total de 570.00M USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Aug 01, 2024
HLN.NB Final Cash Dividend of gross USD 0.051416 paid on Sep 19, 2024 going ex on Aug 16, 2024
Aug 16, 2024
Sep 19, 2024
Aug 16, 2024
Feb 29, 2024
HLN.NB Interim Cash Dividend of gross USD 0.105268 paid on May 16, 2024 going ex on Mar 14, 2024
Mar 15, 2024
May 16, 2024
Mar 14, 2024
Aug 02, 2023
HLN.NB Final Cash Dividend of gross USD 0.043871 paid on Oct 05, 2023 going ex on Aug 24, 2023
Aug 25, 2023
Oct 05, 2023
Aug 24, 2023
Mar 02, 2023
HLN.NB Interim Cash Dividend of gross USD 0.059732 paid on Apr 27, 2023 going ex on Mar 16, 2023
Mar 17, 2023
Apr 27, 2023
Mar 16, 2023
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI